NCT00783679

Brief Summary

The purpose of this study is to test the accuracy of a new noninvasive way to measure how much blood our heart pumps per minute. This new way measures the heart's pumping activity from outside the body, instead of breaking the skin and measuring it from the inside. Subjects will breathe normally through a mask while we record how fast and how much air they are breathing. We will have them "re-breathe" some of the air they breathed out by adjusting the ventilator. During this time, we will use the air breathed out to calculate how much blood per minute the subject's heart is pumping. We will also measure how much blood the heart is pumping at this time by injecting fluid into the catheter in the neck and then drawing about 1 teaspoon of blood from the catheters in the neck and arm. We will compare the calculated and measured values of the amount of blood pumped out of the heart for accuracy. After we complete this procedure, we will remove the mask and allow you to rest for 10-30min. Following the rest period, we will repeat the process and collect a second set of measurements. We will draw a total of 4 teaspoons of blood for the study. If you cannot comfortably breathe along with the ventilator, we will withdraw you from the study. If you want to stop taking part in the study at any time, let the study doctor know that you wish to withdraw. We will take off the mask, and your time in the study will end. This decision will not affect your regular medical care.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2009

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 3, 2008

Completed
12 months until next milestone

Study Start

First participant enrolled

November 1, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

April 25, 2012

Status Verified

April 1, 2012

Enrollment Period

1.1 years

First QC Date

October 30, 2008

Last Update Submit

April 24, 2012

Conditions

Keywords

Cardiac outputNoninvasive cardiac output measurementThermodilution

Outcome Measures

Primary Outcomes (1)

  • To test the feasibility and accuracy of using NICO to measure cardiac output in ventilator assisted patients without tracheal intubation.

    1 year

Study Arms (1)

1

OTHER

Twenty adult spontaneously breathing patients without intubation and mechanical ventilation recruited from the cardiac catheterization laboratory. All will be post-heart-transplant patients coming for yearly evaluation.

Device: NICO device

Interventions

Measurement of cardiac output and simultaneous blood sampling. The subjects' cardiac output will be measured by NICO device and also by thermodilution method. Simultaneously blood samples will be drawn from the pulmonary artery catheter and arterial line. The calculated and measured cardiac output values will be compared for accuracy.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is already monitored with a pulmonary artery catheter and arterial line (not for the purpose of this study);
  • Hemodynamic stability.

You may not qualify if:

  • Patients with facial deformity, heavy beard or moustache which prevents good seal between the mask and the face;
  • Patients who have central nervous system disorders that might be adversely affected by CO2 rebreathing, such as head trauma patients with increased intracranial pressure;
  • Patients with severe tricuspid regurgitation;
  • Patients with intra-cardiac shunts;
  • Patients who cannot cooperate and synchronize with the ventilator;
  • Patients with unstable respiratory conditions, such as acute respiratory failure;
  • Patients who have claustrophobia and cannot wear the mask.
  • Patients with aortic stenosis.
  • Patients with left main coronary artery disease.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Study Officials

  • Robert Kacmarek, PhD, RRT

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia, Director of Respiratory Care Services

Study Record Dates

First Submitted

October 30, 2008

First Posted

November 3, 2008

Study Start

November 1, 2009

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

April 25, 2012

Record last verified: 2012-04

Locations